Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
SUMIDA, 1% Increase in Net Income for The Current Fiscal Year
6817 SUMIDA CORPORATION 【IFRS】
Earnings ReportSUMIDA CORPORATION <6817> [TSE Prime] announced its financial results (based on IFRS) after the market closed on February 6th (17:00). The consolidated net income for the fiscal year ended December 2025 surged by 6.1 times that of the previous term, reaching 3.61 billion yen. For the fiscal year ending December 2026, the consolidated net income is nearly flat with a slight increase of 0.9% to 3.65 billion yen.
In the most recent three-month period, from October to December (4Q), the consolidated net income/loss turned to a profit of 0.94 billion yen (compared to a loss of 0.65 billion yen in the same period last year). The operating profit margin significantly improved from 1.2% in the same period last year to 5.0%.
Kabutan News
Actual Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Dec, 2023 | 147,672 | 8,564 | 5,856 | 5,064 | 167.5 | 51 | Feb 7, 2024 | IFRS |
| Dec, 2024 | 143,978 | 4,513 | 1,295 | 590 | 18.0 | 53 | Feb 7, 2025 | IFRS |
| Dec, 2025 | 147,194 | 7,439 | 4,830 | 3,618 | 109.5 | 53 | Feb 6, 2026 | IFRS |
| YoY | +2.2% | +64.8% | +273.0% | +513.2% | +509.5% |
Full Year Results vs. Previous Guidance
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Dec, 2025 Guidance | 144,000 | 7,000 | 4,080 | 3,200 | 96.8 | 53 | Feb 7, 2025 | IFRS |
| Dec, 2025 Results | 147,194 | 7,439 | 4,830 | 3,618 | 109.5 | 53 | Feb 6, 2026 | IFRS |
| Revision Rate | +2.2% | +6.3% | +18.4% | +13.1% | +13.1% |
Current Period Guidance
H1 Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Jan - Jun, 2025 | 71,170 | 3,364 | 2,174 | 1,667 | 50.5 | 26 | Jul 31, 2025 | IFRS |
| Jan - Jun, 2026 Guidance | ー | ー | ー | ー | - | 26 | Feb 6, 2026 | IFRS |
| YoY | - | - | - | - | - |
Current Period Guidance
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Dec, 2024 | 143,978 | 4,513 | 1,295 | 590 | 18.0 | 53 | Feb 7, 2025 | IFRS |
| Dec, 2025 | 147,194 | 7,439 | 4,830 | 3,618 | 109.5 | 53 | Feb 6, 2026 | IFRS |
| Dec, 2026 Guidance | 156,000 | 7,500 | 4,850 | 3,650 | 110.4 | 53 | Feb 6, 2026 | IFRS |
| YoY | +6.0% | +0.8% | +0.4% | +0.9% | +0.8% |
Quarterly Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Operating Profit Margin | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Oct - Dec, 2024 | 34,442 | 407 | -389 | -652 | -19.9 | 1.2 | Feb 7, 2025 | IFRS |
| Jan - Mar, 2025 | 35,390 | 1,236 | 802 | 585 | 17.7 | 3.5 | Apr 30, 2025 | IFRS |
| Apr - Jun, 2025 | 35,780 | 2,128 | 1,372 | 1,082 | 32.8 | 5.9 | Jul 31, 2025 | IFRS |
| Jul - Sep, 2025 | 36,906 | 2,125 | 1,455 | 1,010 | 30.6 | 5.8 | Oct 31, 2025 | IFRS |
| Oct - Dec, 2025 | 39,118 | 1,950 | 1,201 | 941 | 28.5 | 5.0 | Feb 6, 2026 | IFRS |
| YoY | +13.6% | +379.1% | - | - | - |
Related Articles
Kobe Steel, Apr-Dec (Cumulative 3Q) Ordinary Profit Decreases by 33%, Oct-Dec Ordinary Profit Decreases by 49%
SHIN NIPPON BIOMEDICAL, Ordinary Profit Forecast for the Fiscal Year Revised Downward by 10%
Nikkei 225 close on the 6th = rebound for the first time in 3 days, 435 yen higher to 54,253 yen
KAINOS Laboratories, Postponed Dividend for This Fiscal Year
Cookpad, 44% Decrease in Net Income for the Last Fiscal Year, Current period performance is undisclosed.
MITSUI-SOKO HOLDINGS, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 17%, Oct-Dec Ordinary Profit Increases by 10%
Alue, Ordinary Profit Forecast for Last Fiscal Year Revised Upward by 38%, Highest in Four Terms
FUJITEC, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 26%, Oct-Dec Ordinary Profit Increases by 39%
OncoTherapy Science, Apr-Dec (Cumulative 3Q) Net Income Loss Widens, Oct-Dec Net Income Loss Widens
IPS, First Half Ordinary Profit Increases by 28%